NDC 21130-179 – Guaifenesin
Guaifenesin 600 mg/1 · Tablet, Extended Release · Oral
Product NDC21130-179
Product details
- Brand name
- Guaifenesin
- Generic name
- Guaifenesin
- Labeler
- Better Living Brands LLC
- Dosage form
- Tablet, Extended Release
- Route
- Oral
- Marketing category
- ANDA · ANDA210453
- Marketed since
- April 15, 2022
- Listing expires
- December 31, 2026
- Pharmacologic class
- Expectorant
Active ingredients
- Guaifenesin 600 mg/1
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 21130-179-67 | 1 BLISTER PACK in 1 CARTON (21130-179-67) / 20 TABLET, EXTENDED RELEASE in 1 BLISTER PACK | Apr 15, 2022 |
Other Guaifenesin products
- 80513-413 Guaifenesin 1200 mg/1 · Tablet, Extended Release · Advanced Rx LLC
- 46122-750 Guaifenesin 600 mg/1 · Tablet, Extended Release · AMERISOURCE BERGEN
- 65162-037 Guaifenesin 1200 mg/1 · Tablet, Extended Release · Amneal Pharmaceuticals LLC
- 65162-036 Guaifenesin 600 mg/1 · Tablet, Extended Release · Amneal Pharmaceuticals LLC
- 58602-865 Guaifenesin 1200 mg/1 · Tablet, Extended Release · Aurohealth LLC
- 58602-853 Guaifenesin 600 mg/1 · Tablet, Extended Release · Aurohealth LLC
- 58602-857 Guaifenesin 1200 mg/1 · Tablet, Extended Release · Aurohealth LLC
- 58602-811 Guaifenesin 1200 mg/1 · Tablet, Extended Release · Aurohealth LLC
- 58602-864 Guaifenesin 600 mg/1 · Tablet, Extended Release · Aurohealth LLC
- 58602-810 Guaifenesin 600 mg/1 · Tablet, Extended Release · Aurohealth LLC
- 68001-561 Guaifenesin 600 mg/1 · Tablet, Extended Release · BluePoint Laboratories
- 51316-071 Guaifenesin 600 mg/1 · Tablet, Extended Release · CVS